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PP2APerinuclear reorganization via phosphorylation of speciﬁc serine residues in keratin is involved in the
deformability of metastatic cancer cells. The level of leukotriene B4 is high in pancreatic cancers. However,
the roles of LTB4 and its cognate receptors in keratin reorganization of pancreatic cancers are not known.
LTB4 dose-dependently induced phosphorylation and reorganization of Keratin 8 (K8) and these processes
were reversed by LY255283 (BLT2 antagonist). BLT2 agonists such as Comp A and 15(S)-HETE also induced
phosphorylation of serine 431 in K8. Moreover, Comp A-induced K8 phosphorylation and reorganization
were blocked by LY255283. Gene silencing of BLT2 suppressed Comp A-induced K8 phosphorylation and
reorganization in PANC-1 cells. Over-expression of BLT2 promoted K8 phosphorylation. Comp A promoted
the migration of PANC-1 cells in a dose-dependent manner, and LY255283 blocked Comp A-induced migra-
tion, respectively. PD98059 (ERK inhibitor) suppressed Comp A-induced phosphorylation of serine 431 and
reorganization of K8. Gene silencing of BLT2 suppressed the expression of pERK, and over-expression of
BLT2 increased the expression of pERK even without Comp A. Comp A induced the expression of active
ERK (pERK) and BLT2. These inductions were blocked by PD98059. Comp A decreased PP2A expression
and hindered the binding of PP2A to the K8, leading to the activation of ERK. PD98059 suppressed the
Comp A-induced migration of PANC-1 cells and BLT2 over-expression-induced migration of PANC-1 cells.
Overall, these results suggest that BLT2 is involved in LTB4‐induced phosphorylation and reorganization
through ERK activation by PP2A downregulation, leading to increased migration of PANC‐1 cells.
© 2012 Elsevier B.V. All rights reserved.1. Introduction
Recently, novel approaches have been tested to characterize the
properties of cells such as cell elasticity and mechanical proper-
ties [1,2]. The clinical importance of viscoelasticity or cell stiffness
was shown by several researchers including Cross et al. [3,4]. The
stiffness of live metastatic cancer cells taken from the body (pleural)
ﬂuids of patients with suspected lung, breast and pancreas cancer was
more than 70% softer than that of normal cells [3]. The importance of
cell elasticity or viscoelasticity in several metastatic cancer cell lines
and other diseases has also been reported [5]. For example,
SPC-induced molecular reorganization of keratin in PANC-1 human
epithelial pancreatic cancer cells and the resulting changes in theT2, Leukotriene B4 receptor 2;
, Sphingosylphosphorylcholine;
l papillary mucinous neoplasm
+82 31 961 5463.
l rights reserved.mechanical deformability of cells have been examined as possible
pathways that facilitate migration and increase the metastatic com-
petence of pancreatic tumor cells [6–9].
Leukotriene B4 (LTB4) is a downstreammetabolite of 5-lipoxygenase
(5-LO) [10]. LTB4 stimulates growth and proliferation of pancreatic
cancer cells by activating phosphatidylinositol 3-kinase/ERK [10]. It
has been found that LTB4 levels are signiﬁcantly higher in pancreatic
carcinoma than in tumor-free tissues [11]. Overexpression of its cognate
receptors such as BLT1 or BLT2 has been observed in several cancers
including pancreatic cancers [12–14]. Furthermore, BLT2 levels were
markedly increased in invasive human cancer tissues compared to
non-neoplastic tissues [12,14,15]. More speciﬁcally, BLT2 is expressed
in PanIN, IPMN, and pancreatic cancers [16].Most studies on LTB4 recep-
tors have focused on the high-afﬁnity receptor, BLT1. In contrast, very
little is known about the physiological function of BLT2. Recently, BLT2
signaling was shown to be important in oncogenic Ras-induced cancer
progression in Rat-2 ﬁbroblast cells [17]. BLT2 is also involved in the
regulation of VEGF-induced angiogenesis [18].
Because keratin reorganization is involved in the deformability of
pancreatic cancer cells that lead to efﬁcient migration, we were
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phorylation and reorganization [6]. Previous studies have shown that
several chemicals, proteins and shear stress induce keratin reorgani-
zation in several cell types including the pancreatic cancer cell line
PANC-1 and the gastric cancer cell line AGS [6,19–23]. However, en-
dogenous mediators that evoke keratin reorganization are not well
known. Therefore, we examined whether LTB4 and its cognate recep-
tors are involved in keratin phosphorylation and reorganization in
PANC-1 cells.
In this report, we found that LTB4 induced keratin-8 (K8) phos-
phorylation and reorganization in PANC-1 cells. BLT2 receptor was in-
volved in LTB4-induced in K8 phosphorylation and reorganization of
PANC-1 cells via ERK activation by PP2A downregulation, leading to
increased migration of PANC-1 cells.
2. Materials and methods
2.1. Material
The phosphospeciﬁc antibody detecting K8 Ser 431 was purchased
from Abcam (Cambridge, UK). Peroxidase-labeled secondary anti-
bodies were acquired from Santa Cruz Biotechnology (1:5000, Santa
Cruz, CA, USA). Alexa Fluor 594 goat anti-mouse antibody was
obtained from Molecular Probes, Inc. (1:500, Eugene, OR, USA).
Leukotriene B4, LY255283, 15(S)-HETE, PD98059, SP600125 and
SB203580 were purchased from Cayman Chemical (Ann Arbor, MI).
Compound A was a gift from Dr. Sanghee Kim. It was supplied as a
crystalline solid and then dissolved in dimethylsulfoxide (DMSO) or
ethanol and stored at−20 °C. All of these chemicals were freshly pre-
pared at the time of each experiment. BLT2 plasmid (pBLT2) was
kindly provided by Dr. Shimizu (University of Tokyo).
2.2. Cell culture
Human pancreatic cancer cell lines, namely PANC-1, AsPC1,
BxPC1, HPAC, Capan1, Capan2, and MiaPaCa2 were purchased from
the American Type Culture Collection (Manassas, VA). Stocks were
maintained in DMEM supplemented with 10% (v/v) fetal bovine
serum (FBS) and 1% penicillin-streptomycin in a humidiﬁed atmo-
sphere of 5% carbon dioxide and 95% air at 37 °C and were passaged
every 3 days. Cells were washed twice in serum-free DMEM and sub-
sequently incubated in serum-free DMEM for 15 hours before the re-
spective experiments.
2.3. Western Blot
After incubation, the cells were collected and washed twice with
cold PBS. The cells were lysed in lysis buffer [50 mM Tris–HCl (pH
7.5), 150 mM NaCl, 1% Triton X-100, 2 mM EDTA, 1% Deoxycholic acid
(DOC), 0.1% SDS, 1 mMNaVO3, 10 mMNaF, 1 mMDTT] and centrifuged
to yield whole-cell lysates. Protein concentration was measured by the
Bradford method. Aliquots of the lysates (10 μg of protein) were sepa-
rated on 10% SDS-polyacrylamide gels and then transferred onto
polyvinylidene ﬂuoride (PVDF) or nitrocellulose (NC) membranes
(Invitrogen, Carlsbad, CA)with glycine transfer buffer [192 mMglycine,
25 mM Tris–HCl (pH 8.8), 10% MeOH (v/v)]. After blocking the
nonspeciﬁc sites with 5% non-fat dry milk, the membrane was then in-
cubated with speciﬁc primary antibody in 3% bovine serum albumin
(BSA) at 4 °C overnight. The following primary antibodies were used:
anti-cytokeratin 8 (1:1000, Abcam, Cambridge, MA); anti-ß-actin
(1:1000, Santa Cruz Biotechnology, Inc., Santa Cruz, CA), anti-BLT2
(1:200, Cayman Chemical, Ann Arbor, MI), anti-PP2A (1:1000,
BD Transduction Laboratories, Franklin Lakes, NJ), 5-lipoxygenase
(1:1000, Abcam, Cambridge, MA), 12-lipoxygenase (1:1000, Abcam,
Cambridge, MA), phospho-ERK (1:1000, Cell Signaling, Beverly, MA),
ERK (1:1000, Cell Signaling, Beverly, MA). The membrane was furtherincubated for 60 min with HRP-labeled anti-rabbit or anti-mouse IgG
secondary antibody (1:5000, Santa Cruz, CA) at room temperature.
The protein-antibody complexes were detected by HRP–conjugated
secondary antibodies followed by enhanced chemiluminescence West-
ern blotting detection reagents (Amersham, Arlington Heights, IL).
2.4. Confocal microscopy
Cells were seeded onto coverslips and treated with chemicals.
24 h later, cells were ﬁxed with 100% methanol for 30 min at room
temperature and permeabilized with 0.1% Triton X-100 for 10 min
followed by several washes with PBS. After blocking with 3% BSA in
PBS at room temperature for 1 h, anti-cytokeratin 8 (1:250, Abcam,
Cambridge, UK) primary antibody was incubated with coverslips
overnight at 4 °C. Excess antibody was removed with PBS and then
species-speciﬁc secondary antibody conjugated to Alexa Fluor 594
goat anti-mouse antibody obtained from Molecular Probes, Inc.
(1:500, Eugene, OR, USA) was reacted with the coverslips for 1 h at
room temperature. Followed by four washes in PBS, the slides were
mounted with mounting solution and visualized using a Zeiss
Axiophot confocal microscope (400×).
2.5. Transfection with small interference RNA (siRNA) or plasmid
containing BLT2
PANC-1 cells were seeded into 6-well microplates in DMEM
supplemented with 10% FBS without antibiotics. BLT2 siRNA (sense
CCACGCAGUCAACCUUCUGTT, antisense CAGAAGGUUGACUGCGUGG
TA) was purchased from Samchully Pharm. For siRNA or BLT2 trans-
fection experiments, the cells were plated on 6-well plates until
they reached 70% conﬂuence and were then transfected with BLT2
siRNA (100 pmol) or plasmid containing BLT2 using Lipofectamine™
2000 reagent according to the manufacturer's instructions. 48 hours
after transfection, PANC-1 cells were grown in complete culture me-
dium. After this, the cells were starved for 15 hours and treated
with speciﬁc chemicals. Proteins were extracted from the cells and
analyzed by Western blot.
2.6. Immunoprecipitation
The cell extracts (typically 600 μg) were prepared with protein A
beads before being incubated with the appropriate antibody for
2 hours, followed by addition of more protein A beads for an additional
hour. The beads were washed with lysis buffer before being boiled in
the SDS sample buffer and then subjected to SDS PAGE and Western
blotting. The phosphospeciﬁc antibody detecting K8 Ser431 (1:1000,
Abcam, Cambridge, MA) was used for immunoprecipitation.
2.7. Migration
Migration of PANC-1 cells through 8-μm size-limited pores was
assessed in response to LTB4 according to Park's report [24]. PANC-1
cells (5×104 cells per well) were treated with the indicated concentra-
tions of LTB4, Compound A, or 15(S)-HETE for 1 hour. PANC-1 cells
plated in the upper chamber were allowed to migrate for 5 hours to es-
tablish the temporal kinetics of migration. The transwell membranes
were then ﬁxed and stained with Diff-Quik® staining kit (Kobe,
Japan). Membranes were removed from transwells, and cells on the
undersurface of the millipore membrane were counted under a light
microscope (average of 5 semi-random non-overlapping ﬁelds at
200x magniﬁcation). All treatments were performed in triplicate wells.
2.8. Flow cytometry analysis
For surface staining of BLT2, a total of 5×105 cells were harvested
and blocked with 10% bovine serum albumin in FACS buffer (PBS with
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incubated with the primary antibody against BLT2 (1:100 dilution)
(Cayman Chemical Company Ann Arbor, MI) for 1 h, and washed
three times with FACS buffer. Cells incubated with anti-rabbit-Alexa
488 (1:500, Molecular Probes) for 30 min, and washed three times
with FACS buffer. BLT2 receptor expression was analyzed with a FACS
Calibur ﬂow cytometer.
2.9. Statistical analysis
The data are expressed as mean±s.e.m. of at least three indepen-
dent experiments performed in triplicate. A p valueb0.05 was consid-
ered signiﬁcant.
3. Results
3.1. Effects of LTB4 on K8 organization and phosphorylation
The effect of LTB4 on K8 phosphorylation was examined using a
speciﬁc monoclonal antibody for serine 431 (Ser431) of K8 in several
pancreatic cancer cell lines, namely PANC-1, HPAC, BXPC3, ASPC1,
Capan2, and MiaPaCa2 (Fig. S1). After this, the effects of LTB4 on the
phosphorylation of serine residues in K8 were examined with
site-speciﬁc phosphoserine K8 antibodies, anti-Ser23, anti-Ser73,
and anti- Ser431, in PANC-1 cells which is well-characterized cells
suited to examine keratin phosphorylation and reorganization [6–8].
We found that phosphorylation of Ser431 of K8 was remarkable in
LTB4-treated PANC-1 cells (Fig. S2). Thus, subsequent studies were
performed in PANC-1 cells with antibody speciﬁc for Ser431 of K8.
LTB4 dose-dependently induced phosphorylation of keratin-8 in
PANC-1 and ASPC-1 cells (Fig. 1A). Maximum phosphorylation of
K8-serine 431 (Ser431) was achieved at 50 nM LTB4. An increased in-
duction of phosphorylation of K8 was ﬁrst detected after 30 min and
reached a maximum after 1-hour of incubation with LTB4 (Fig. 1B).
PANC-1 and ASPC-1 cells exhibited the typical pan-cytoplasmic pat-
tern of keratin ﬁlaments (Figs. 1C, S3). LTB4 induced reorganization of
keratin ﬁlaments to a perinuclear, ring-like structure (Figs. 1C, S3).
This effect was rapid, reaching a maximum after 1 hour (Figs. 1D, S4).
3.2. Effects of LY255283, Compound A, and 15(S)-HETE on LTB4-induced
K8 phosphorylation and reorganization
The involvement of BLT2 receptor in LTB4-induced K8 phosphoryla-
tion and perinuclear reorganization was conﬁrmed with the BLT2 re-
ceptor antagonist LY255283 or BLT2 agonists such as 15(S)-HETE and
Compound A (Comp A, Fig. S5). LY255283, a well-known BLT2 antago-
nist, suppressed the LTB4-induced phosphorylation and reorganization
of K8 (Figs. 2A, B, S6). However, U75302, awell-knownBLT1 antagonist,
did not prevent LTB4-induced K8 events (Fig. S7). We also tested
whether the BLT2 agonists, Comp A or 15(S)-HETE induced phosphory-
lation of K8. The results showed that CompA or 15(S)-HETE induced K8
phosphorylation and reorganization (Fig. 2C, D). Comp A-induced
phosphorylation and reorganization of K8 were also suppressed by
LY255283 (Figs. 2E, F, S8).
3.3. Effects of BLT2 gene silencing and overexpression on Comp A-induced
K8 phosphorylation and reorganization
To examine the involvement of BLT2, we mainly used Comp A in
the following experiments instead of LTB4 since Comp A is speciﬁc
for BLT2. The involvement of BLT2 receptor in Comp A-induced K8
phosphorylation and perinuclear reorganization was conﬁrmed with
BLT2 receptor gene silencing (siBLT2) and overexpression (pBLT2).
Gene silencing of BLT2 suppressed the Comp A-induced phosphoryla-
tion and reorganization of K8 (Fig. 3A, B). Gene silencing of BLT2 also
suppressed the LTB4-induced phosphorylation of K8 (Fig. S9). Genesilencing of BLT2 was conﬁrmed by Western blot (Fig. 3A). Transfec-
tion of the BLT2 gene (pBLT2) induced phosphorylation and reorgani-
zation of K8 in PANC-1 cells (Fig. 3C, D). Overexpression of BLT2 was
also conﬁrmed by Western blot (Fig. 3C).
3.4. Effect of LY255283 on Comp A-induced migration of PANC-1 cells
The expected ﬁnal output of Comp A-induced reorganization of
the keratin network in PANC-1 cells was increased migratory proper-
ties [6]. Therefore, the involvement of BLT2 in the Comp A-induced
migration of PANC-1 cells was examined using LY255283. At ﬁrst,
we conﬁrmed whether a BLT2 agonist, Comp A, induced the migra-
tion of PANC-1 cells. PANC-1 cells were treated for 1 hour with vari-
ous amounts Comp A ranging from 10 nM to 100 nM. Comp A
induced the migration of PANC-1 cells in a dose-dependent manner.
At 50 nM, the increase in migration reached a maximum (Fig. 4A).
LY255283, a BLT2 antagonist, suppressed the Comp A-induced migra-
tion of PANC-1 cells (Fig. 4B). LTB4 also induced the migration of
PANC-1 cells, but LY255283 suppressed it (Figs. S10, S11). These re-
sults suggest that BLT2 is involved in LTB4- or Comp A-induced
migration.
3.5. Effect of ERK inhibitor on Comp A-induced K8 phosphorylation and
reorganization
MAP kinase is believed to be involved in K8 phosphorylation and re-
organization in PANC-1 cells [6], but a detailed study using kinase inhib-
itors has not been done. Therefore, the effects of several kinase inhibitors
on Comp A-induced phosphorylation of K8 were examined in PANC-1
cells. PD98059 (MEK1 inhibitor) suppressed the Comp A-induced phos-
phorylation and reorganization of K8 (Figs. 5A, B, S12, S13). PD98059
also suppressed the LTB4-induced phosphorylation of K8 (Fig. S14).
Next, the relationship between BLT2 and ERKwas examined. CompA in-
duced phosphorylation of ERK in wild-type PANC-1 cells, but the phos-
phorylation was repressed in BLT2-silenced PANC-1 cells (Fig. 5C).
Overexpression of BLT2 induced ERK activation (Fig. 5D). Comp A also
induced BLT expression and this induction was suppressed by gene si-
lencing of BLT2 (Fig. 5C, D). Comp A-induced migration of PANC-1 cells
was suppressed by PD98059, and overexpression of BLT2 increased the
migration of PANC-1 cells; this migration was also inhibited by
PD98059 (Fig. 5E). Comp A also affected the expression of PP2A and
the inverse relationship between pERK and PP2A was observed with
CompA treatment (Fig. 5F). PP2A andpERKwere coimmunoprecipitated
with phosphoserine antibody speciﬁc for Ser431 of K8. Compound A
treatment decreased PP2A binding but increased pERK binding to K8
(Fig. 5G). Comp A induced BLT2 expression and this expression was
suppressed by PD98059 (Fig. 5H). These ﬁndings were also conﬁrmed
by ﬂow cytometry (Fig. S15).
4. Discussion
Metastatic cancer cells are reported to have unique mechanical
characteristics including soft stiffness and less elasticity [3]. Keratins
are one of the main intermediate ﬁlaments that control the mechan-
ical characteristics of cells [25]. Precise characterization of the dy-
namic functions of keratin in vivo has been hampered by the fact
that very few physiological regulators are known to speciﬁcally trig-
ger keratin reorganization and phosphorylation. This study focused
on the effects of LTB4 on keratin reorganization in pancreatic cancer
cells including PANC-1 cells and on the underlying mechanisms in
the migratory properties of PANC-1 cells. The effects of inﬂammatory
mediators such as LTB4 on keratin phosphorylation and reorganiza-
tion have not been investigated, although inﬂammation is regarded
as one of the hallmarks in cancer [26]. Such ﬁndings along with the
fact that LTB4 levels and BLT2 expression are high in these cancers
evoked our interest in the role and the related mechanisms of LTB4
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D
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Fig. 1. LTB4 induces phosphorylation and reorganization of keratin 8 in PANC-1 and AsPC1 cells. (A) Dose dependency of LTB4-induced serine 431 (Ser431) phosphorylation of K8 in
PANC-1 and AsPC1 cells (B) Time dependent phosphorylation of Ser431 of K8 in PANC-1 and AsPC1 cells. (C) Confocal microscopic examination of phosphorylation of Ser431 in K8
of PANC-1 cells. (D) Confocal microscopic examination of time-dependent phosphorylation of Ser431 in K8 of PANC-1 cells. In (B), (C), and (D), cells were treated with 50 nM LTB4
for the times indicated. In (A) and (B), phosphorylated Ser431 was analyzed byWestern blotting with a monoclonal antibody speciﬁc for phospho-Ser431 of K8. Blots were stripped
and reprobed with β-actin antibody. In (C) and (D), immunostaining was performed using K8-Ser431 (red) or panK8 (green). The results shown are representative of three inde-
pendent experiments with similar results.
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LTB4-induced keratin phosphorylation and reorganization, which
are related to deformability and migration of cancer cells [6,7,27].
Using ﬂuorescence microscopy, we demonstrated that LTB4 rapid-
ly induced a redistribution of intact keratin ﬁlaments from the cell pe-
riphery to the perinuclear region (Fig. 1C, D). K8 is one of the
intermediate ﬁlaments consisting of a conserved central coiled-coil
α-helical rod domain that is ﬂanked by N- (head) and C-terminal
(tail) domains [23]. Three phosphorylation sites have been reported
for K8, namely K8pSer23, K8pSer73, K8pSer431 [28]. Phosphorylation
of K8 is regulated by various protein kinases such as PKC and
mitogen-activated protein kinase (MAPK) [29–32]. The effects of
LTB4 on phosphorylation of Ser431 of K8 were examined in several
pancreatic cancer cell lines, including PANC-1, HPAC, BxPC3, AsPC3,Capan2, and MiaPaCa2 cells (Fig. S1). LTB4-induced K8 phosphoryla-
tion in MiaPaCa2, BxPC3, and Capan2 is less signiﬁcant than other
pancreatic cancer cell lines. It is not known why pancreatic cancer
cell lines respond differently. We could not ﬁnd any correlation
between K8 phosphorylation and the characteristics of pancreatic
cancer cell lines, such as grade of differentiation and origin [33]. The
phosphorylated status of K8 in MiaPaCa2 and BxPC3 without LTB4
treatment was higher than those of other pancreatic cancer cell
lines (Fig S1). Thus, MiaPaCa2 and BxPC3 cells did not respond well
with LTB4 treatment. Pancreatic cancer cell lines contain Ras mutation
leading to Raf/MEK/MAPK activation, and MAPK is known to phos-
phorylate serine 431 of K8 [8,34–36]. Therefore, these different
responses in different pancreatic ductal adenocarcinoma cell lines
might be contributed by different intracellular environments
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Fig. 2. BLT2 is involved in LTB4-induced K8 phosphorylation and reorganization of PANC-1 and AsPC1 cells. (A) Effect of LY255283 on LTB4-induced K8 phosphorylation. PANC-1 or AsPC1
cells were treated with varying amounts of LY255283 and LTB4 (50 nM). (B) Confocal microscopic examination of the effect of LY255283 on LTB4-induced K8 phosphorylation of PANC-1
cells. (C) Dose dependency of Compound A (Comp A)-induced serine 431 (Ser431) phosphorylation of K8 in PANC-1 or AsPC1 cells. (D) Dose dependency of 15(S)-HETE-induced serine
431 (Ser431) phosphorylation of K8 in PANC-1 or AsPC1 cells. (E) Effect of LY255283 on Comp A-induced K8 phosphorylation. PANC-1 or AsPC1 cells were treated with varying amounts of
LY255283 and Comp A (50 nM). (F) Confocal microscopic examination of the effect of LY255283 on Comp A-induced K8 phosphorylation. In (A), (C), (D) and (E), phosphorylated Ser431
was analyzed byWestern blotting with amonoclonal antibody speciﬁc for phospho-Ser431 K8. Blots were stripped and reprobedwith β-actin antibody. In (B) and (F), immunostainingwas
performed using K8-Ser431 (red) or panK8 (green).
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atin [16]. However, these notions may require further research.
The exact phosphoserine residues of K8 affected by LTB4 were de-
termined by site-speciﬁc phosphoserine K8 antibodies, anti-Ser23,
anti-Ser73, and anti-Ser431. Phosphorylation of Ser431 of K8 was re-
markable in LTB4-treated PANC-1 cells (Fig. S2). Since SPC-induced
phosphorylation in Ser431 of K8 is already well-deﬁned, we focused
on the effects of LTB4 on phosphorylation of Ser431 in K8 [6]
(Fig. 1A, B). Several inducers, such as EGF, phosphatase inhibitor
and sheared stress, can induce phosphorylation and reorganization
of keratin in many types of cells [22,23,31]. In particular, SPC-
induced keratin reorganization via phosphorylation is related to the
viscoelasticity and migration of tumor cells [6,7]. Moreover, LTB4 is
among the compounds that induce keratin phosphorylation and reor-
ganization (Fig. 1).A
SiBLT2
K8-Ser431
β-actin
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B
Con Comp A  
BLT2
siRNA
BLT2
siRNA + 
Comp A 
panK8 
55kDa
44kDa
43kDa
52kDa
K8-Ser431
panK8 
Comp A (50nM)  -       +    mock  - +
Fig. 3. Effects of BLT2onphosphorylationof Ser431 inK8 inPANC-1 cells. (A) Effects of BLT2 gene s
amounts of BLT2 siRNAs or control siRNA (mock) and stimulated with or without Comp A, respect
CompA-induced reorganizationof K8. (C) Effects of BLT2overexpression onphosphorylationof Ser
(50 nM) for 1 hour after transfection with the plasmid containing BLT2 (pBLT2) and control (m
A-induced reorganizationof K8. In (B) and (D), immunostainingwasperformedusingK8-Ser431 (r
Blots were stripped and reprobed with β-actin antibody.LTB4 is a product of 5-LO and acts via BLT1 and BLT2 receptors.
BLT1 and BLT2 are expressed in pancreatic cancers [12,16]. LTB4-
induced phosphorylation and reorganization of K8 were inhibited
by LY255283, but U755302, a BLT1 antagonist, did not suppress the
LTB4-induced phosphorylation and reorganization of K8 (Figs. 2, S7).
The involvement of BLT2 was conﬁrmed by Comp A or 15(S)-HETE,
speciﬁc BLT2 agonists, and the increased phosphorylation of K8 by
Comp A was also suppressed by LY255283 (Fig. 2). Different concen-
trations of LY255283 were used in Fig. 2A and E. Comp A is known as
a higher afﬁnity agonist than LTB4 [37]. These amounts used were not
cytotoxic to PANC-1 or AsPC1 cells in our experimental conditions
(Fig. S 16). Thus, higher concentrations of LY255283 were used to
suppressed the Comp A-induced BLT2 activation than the LTB4-
induced BLT2 activation. These relationships between Comp A and
LY255283 were also observed in our previous paper [38]. The sup-
pressive effects of LY255283 were conﬁrmed by gene silencing of
BLT2.
Overexpression of BLT2 led to increased phosphorylation of K8.
Taken together, these observations suggest that BLT2 is involved in
LTB4-induced phosphorylation and reorganization of K8 in PANC-1
cells.
Migration of PANC-1 cells through size-limited pores was increased
by CompAor LTB4 via keratin reorganization (Figs. 4A, S10). CompA- or
LTB4-induced migration of PANC-1 cells was suppressed by LY255283
(Figs. 4B, S11). These results suggest that BLT2 was involved in Comp
A- or LTB4-inducedmigration and the fact that BLT2‐mediated reorgani-
zation and phosphorylation of keratin in PANC-1 cells led to increased
deformability may in part explain the BLT2-mediated migration of
PANC-1 cells induced by Comp A or LTB4 (Figs. 4, S10, S11). BLT2D
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Fig. 4. BLT2 is involved in Comp A-induced migration of PANC-1 cells. (A) Migration of
PANC-1 cells through 8-μm size-limited pores in response to Comp A. (B) Effect of
LY255283 on Comp A-induced migration of PANC-1 cells. In (A), and (B), PANC-1
cells (5×104 cells per well) were treated with Comp A (50 nM) and varying concentra-
tions of LY255283 as indicated for 1 hour. A representative of three independent
experiments+s.e.m., each performed in triplicate, is shown. *pb0.05 compared to con-
trol, **pb0.05 compared to Comp A (50 nM).
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BLT2 is low in normal pancreas [16]. BLT2 is also highly expressed in
bladder cancer, causing survival and metastasis of cancer cells [39].
However, the role of BLT2 and its underlying mechanism in the metas-
tasis of pancreatic cancer cells are not clear. Phosphorylation and reor-
ganization of K8 mediated by BLT2 might contribute to the metastatic
properties of pancreatic cancers by enhancing deformability. Enhanced
deformability allows PANC-1 cells to squeeze through size-limited
spaces [6,7].
Nothing is known about how BLT2 promotes phosphorylation and
reorganization of K8. Since phosphorylation and reorganization of ker-
atin occurs via PKC and MAP kinases, and LTB4 stimulates growth of
pancreatic cancer cells via MAPK pathways [8,9], BLT2 might induce
keratin phosphorylation and reorganization via PKC and MAPK path-
ways [6,10]. Another possibility is activation of ROS by BLT2 [14,17].
Our data showed that BLT2 induced ERK activation in PANC-1 cells,
leading to keratin reorganization and increased migration of PANC-1
cells (Fig. 5). A relationship between BLT2 and ERK was also observed
in mouse keratinocytes [37]. BLT2 signaling has been reported to regu-
late the expression of cyclooxygenase-2 through the RAS/RAF/ERK
pathway [40].
BLT2 overexpression enhanced phosphorylation of Ser431 in K8 and
migration in the absence of LTB4 (Figs. 3C, 5E). There is no report on how
BLT2 can overexpress itself without comp A treatment and induce syn-
thesis of BLT2 ligands such as LTB4 or 12(S)-HETE in PANC-1 cells. How-
ever, overexpression of BLT2 itself exerts matrix metalloproteinase-1
expression in HaCaT cells [41]. Furthermore, BLT2 overexpression itselfis shown to induce the production of LTB4 or 12(S)-HETE, ligands of
BLT2 via 5-lipoxygenase and 12-lipoxygenase in Rat2 cells [42]. There-
fore, it is plausible that BLT2 overexpression itself might enhance the
phosphorylation via increasing the synthesis of BLT2 ligands. We con-
ﬁrmed the expression of 5-lipoxygenase and 12-lipoxygenase, which
were involved in the synthesis of BLT2 ligands such as LTB4 or 12(S)-
HETE, respectively (Fig. 3C).
Reduced expression of PP2A is observed via Comp A treatment
(Fig. 5F). Changes of PP2A expression might be the new mechanism
for ERK activation and phosphorylation of K8. PP2A is reported to be
involved in the phosphorylation of Ser 431 in K8 after hypoosmotic
stress conditions [43]. PP2A can directly dephosphorylate pERK [44].
A detailed mechanism of PP2A's action is not clear and the related
studies are currently underway.
We also examined the expression of PP2A in pancreatic cancer
cells. We found that the expression of PP2A was reduced in MiaPaCa2
and BxPC3 cell lines (Fig. S17). These results might explain the in-
creases of K8 phosphorylation in these two cell lines with no treat-
ment (Fig. S1). These results also suggest that different expression
levels of PP2A in pancreatic cancer cells contribute the factors that ex-
plain the response of keratin phosphorylation in different pancreatic
cancer cell lines.
Fig. 5H shows that the Comp A-induced BLT2 expression was
suppressed by PD98059. The ﬁnding that PD98059 suppressed the
expression of BLT2 suggests the involvement of the ERK pathway in
the expression of BLT2. To our knowledge, there is no report about
the details on the interaction of transcription factors and the promot-
er region of BLT2 and cloning of the promoter region of BLT2. There-
fore, we estimated the binding site for transcription factors in the
upstream sequences of BLT2 using the UCSG genome browser. Up-
stream regions of BLT2 have many possible binding sequences for
transcription factors such as FosB, Fra-1, HSF1, PPAR-γ1, γ2, c-fos,
c-jun, and c-Myc, which are known to be the substrates of ERK [45].
As a result, Comp A induces basal BLT2 activation leading to increased
ERK activity and ERK phosphorylates transcription factors resulting in
binding to the promoter region of BLT2 and enhances the transcrip-
tion of BLT2. PD98059 inhibited ERK activation via blocking the bind-
ing of transcription factors to the promoter region of BLT2, resulting
in suppression of BLT2 expression.
All together, LTB4 induced K8 phosphorylation and reorganization
via BLT2/ERK activation through decreased expression of PP2A in
PANC-1 cells (Fig. 5I). This suggests that BLT2 plays an active role in
the deformability of metastatic cancer cells by inducing K8 reorgani-
zation, and BLT2 could be a new target to modulate phosphorylation
and reorganization of K8, which may alter the viscoelasticity and
deformability of cells.Conﬂict of interest statement
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Fig. 5. ERK activation is dependent on BLT2. (A) Effect of several kinase inhibitors on Comp A-induced keratin phosphorylation in PANC-1 cells. PANC-1 cells were treated with or with-
out 50 nM Comp A for 1 hour in the presence of PD98059 (MEK inhibitor, 10 μM), SP600125 (JNK inhibitor, 5 μM), and SB203580 (p38 kinase, 10 μM). (B) Confocal microscopic ex-
amination of the effects of PD98059 on Comp A-induced K8 phosphorylation in PANC-1 cells. (C) Effect of BLT2 gene silencing on Comp A-induced activation of ERK in PANC-1 cells.
PANC-1 cells were treated with or without 50 nM Comp A for 1 hour after transfection with BLT2 siRNA (50 pmol) and control siRNA (mock). (D) Effect of BLT2 overexpression on
Comp A-induced ERK activation in PANC-1 cells. PANC-1cells were treated with or without 50 nM Comp A for 1 hour after transfection with the plasmid containing BLT2 (pBLT2)
and control (mock). (E) Effect of ERK inhibitor, PD98059 at 10 μMon themigration of PANC1WT. PANC1BLT2 cells (5×104 cells per well) were used inmigration assay. *pb0.05 compared
with control, **pb0.05 compared with LTB4. (F) Effect of Comp A on PP2A expression in PANC-1 cells. PANC-1 cells were treated with or without 50 nM Comp A. Immunostaining was
performed using PP2A antibody. (G) Binding of PP2A with pSer431 of K8. Immunoprecipitation with the 431 phosphoserine-speciﬁc keratin 8 antibody (IP: K8-Ser431) was performed
on the extracts of PANC-1 cells with or without 50 nM Comp A for 1 hour. The resulting immunocomplexes were immunoblotted with PP2A, pERK, 431 phosphoserine-speciﬁc keratin
8 antibodies. IgG was used as negative control. (H–I) Effect of PD98059 on Comp A-induced ERK activation and BLT2 expression in PANC-1 cells. PANC-1 cells were treated with or with-
out 50 nM Comp A for 1 hour in the presence of PD98059 (MEK inhibitor, 10 μM). In (H), pERK, ERK, and BLT2 were analyzed byWestern blot. (I) Signaling pathway of BLT2-involved
keratin 8 phosphorylation.
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